Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
vaccine reactogenicity
Description:
Vaccine reactogenicity is the capacity of a vaccine to cause expected, short-term inflammatory signs and symptoms following immunization.
Related topics:
SARS-CoV-2 and COVID-19 Research (20%),
Bacterial Infections and Vaccines (15%),
Influenza Virus Research Studies (13%)
OpenAlex ID:
keywords/vaccine-reactogenicity
Nanomaterial Delivery Systems for mRNA Vaccines
2021
·
Michael D. Buschmann
, Manuel J. Carrasco
, et al.
·
Vaccines
·
634
PDF
The how’s and what’s of vaccine reactogenicity
2019
·
Caroline Hervé
, Béatrice Laupèze
, et al.
·
npj Vaccines
·
577
PDF
The emergence and epidemic characteristics of the highly mutated SARS‐CoV‐2 Omicron variant
2022
·
Dandan Tian
, Yanhong Sun
, et al.
·
Journal of Medical Virology
·
520
A Comparative Efficacy Trial in Germany in Infants Who Received Either the Lederle/Takeda Acellular Pertussis Component DTP (DTaP) Vaccine, the Lederle Whole-Cell Component DTP Vaccine, or DT Vaccine
1998
·
Klemens Stehr
, James D. Cherry
, et al.
·
PEDIATRICS
·
517
Phase 1 Trial of Malaria Transmission Blocking Vaccine Candidates Pfs25 and Pvs25 Formulated with Montanide ISA 51
2008
·
Yimin Wu
, Ruth D. Ellis
, et al.
·
PLoS ONE
·
507
PDF
Prevention and Control of Influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
2004
·
PsycEXTRA Dataset
·
472
Anti-PEG Antibodies Boosted in Humans by SARS-CoV-2 Lipid Nanoparticle mRNA Vaccine
2022
·
Yi Ju
, Wen Shi Lee
, et al.
·
ACS Nano
·
411
PDF
Distinguishing features of current COVID-19 vaccines: knowns and unknowns of antigen presentation and modes of action
2021
·
Franz X. Heinz
, Karin Stiasny
·
npj Vaccines
·
410
PDF
Comparative Safety of Vaccine Adjuvants: A Summary of Current Evidence and Future Needs
2015
·
Nikolai Petrovsky
·
Drug Safety
·
401
PDF
Blood Stage Malaria Vaccine Eliciting High Antigen-Specific Antibody Concentrations Confers No Protection to Young Children in Western Kenya
2009
·
Bernhards R. Ogutu
, Odika J. Apollo
, et al.
·
PLoS ONE
·
387
PDF
Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort study
2021
·
David Hillus
, Tatjana Schwarz
, et al.
·
The Lancet Respiratory Medicine
·
359
PDF
New initiatives for the control of Japanese encephalitis by vaccination:
2000
·
Theodore F Tsai
·
Vaccine
·
342
Vaccine adjuvants: Current challenges and future approaches
2008
·
Jennifer H. Wilson-Welder
, Maria P. Torres
, et al.
·
Journal of Pharmaceutical Sciences
·
341
PDF
Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells
2021
·
Jose Mateus
, Jennifer M. Dan
, et al.
·
Science
·
336
Safety and immunogenicity of a recombinant M2e–flagellin influenza vaccine (STF2.4xM2e) in healthy adults
2011
·
Christine B. Turley
, Richard E. Rupp
, et al.
·
Vaccine
·
320
Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trial
2014
·
Robert C Read
, David Baxter
, et al.
·
The Lancet
·
309
PDF
Multicenter, Open‐Label, Randomized Phase II Controlled Trial of an Investigational Recombinant Meningococcal Serogroup B Vaccine With and Without Outer Membrane Vesicles, Administered in Infancy
2010
·
Jamie Findlow
, Ray Borrow
, et al.
·
Clinical Infectious Diseases
·
280
Comparison of 13 Acellular Pertussis Vaccines: Adverse Reactions
1995
·
Michael D. Decker
, Kathryn M. Edwards
, et al.
·
PEDIATRICS
·
280
Comparative systematic review and meta-analysis of reactogenicity, immunogenicity and efficacy of vaccines against SARS-CoV-2
2021
·
Ian McDonald
, Sam M. Murray
, et al.
·
npj Vaccines
·
274
PDF
Clinical Responses to Undiluted and Diluted Smallpox Vaccine
2002
·
Sharon E. Frey
, Robert B. Couch
, et al.
·
New England Journal of Medicine
·
271
Cold-adapted live influenza vaccine versus inactivated vaccine: systemic vaccine reactions, local and systemic antibody response, and vaccine efficacy
2002
·
W.E.P Beyer
, A.M Palache
, et al.
·
Vaccine
·
262
Vaccines against meningococcal serogroup B disease containing outer membrane vesicles (OMV): Lessons from past programs and implications for the future
2013
·
Johan Holst
, Philipp Oster
, et al.
·
Human Vaccines & Immunotherapeutics
·
248
PDF
Efficacy trial of single-dose live oral cholera vaccine CVD 103-HgR in North Jakarta, Indonesia, a cholera-endemic area
2000
·
E Richie
, N H Punjabi
, et al.
·
Vaccine
·
242
Impact of anti-PEG antibodies induced by SARS-CoV-2 mRNA vaccines
2022
·
Yi Ju
, Juan Manuel Carreño
, et al.
·
Nature reviews. Immunology
·
229
PDF
Coronavirus Disease 2019 (COVID-19) Vaccines and Pregnancy: What Obstetricians Need to Know
2020
·
Sonja A. Rasmussen
, Colleen F. Kelley
, et al.
·
Obstetrics and Gynecology
·
223
Show more works
View as search
Works count:
1,632
Citation count:
36,300
Year
Topic
Type